News – LinqMed Inc. – Innovative “Visible” Anti-Cancer Treatment with Radiopharmaceuticals

Innovative “Visible” Anti-Cancer Treatment with Radiopharmaceuticals

menu

Japanese

Latest info
Company

Phase I Clinical Trial Results of ⁶⁴Cu-ATSM Radioligand Therapy for Recurrent Malignant Brain Tumors Published in ESMO Open, a Peer-Reviewed Journal

LinqMed Selected for the UK Program Following the Pitch Contest at the Nakanoshima Qross Innovation Challenge

Demonstration of the Efficacy of Hypoxia-Targeted Local Radiotherapy for Malignant Brain Tumors

LinqMed Announces Completion of the Chiba Factory

LinqMed Announces the Final Close of Series B

READ MORE

LOADING...

9th DBJ Women’s New Business Plan Competition DBJ Women’s Entrepreneur Excellence Award

The 21st “Venture Cup CHIBA” Grand Prix Award

LinqMed Co., Ltd. was established.